￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Medical News

What to do after afatinib is resistant to lung squamous cell carcinoma?

2025-10-19 11:44:20

Check Details
Contraindications and medication precautions for patients taking crizotinib

2025-10-19 11:44:20

Check Details
Crizotinib has significant efficacy in treating ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
The effect of afatinib treatment on patients with lung squamous cell carcinoma

2025-10-19 11:44:20

Check Details
Safety and effectiveness of larotrectinib in the treatment of non-small cell lung cancer

2025-10-19 11:44:20

Check Details
How much will a box of crizotinib cost after it is included in medical insurance in 2021?

2025-10-19 11:44:20

Check Details
Larotinib shows remarkable results in the treatment of NTRK mutation-positive lung cancer patients

2025-10-19 11:44:20

Check Details
Crizotinib has significant anti-cancer effect on ROS1-rearranged advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Nivolumab returns to the "battlefield" and joins forces with chemotherapy to help treat non-small cell lung cancer

2025-10-19 11:44:20

Check Details
FDA Grants Crizotinib Breakthrough Drug for ROS1-Rearranged Advanced Non-Small Cell Lung Cancer_Cornhule

2025-10-19 11:44:20

Check Details
A new first-line treatment option for ALK-positive non-small cell lung cancer-crizotinib

2025-10-19 11:44:20

Check Details
The emergence of larotrectinib gives lung cancer patients an additional choice

2025-10-19 11:44:20

Check Details
Category
相关知识